Glassman Wealth Services V Tv Therapeutics Inc. Transaction History

Glassman Wealth Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.39 - $0.84 $0 - $0	-1 Closed	0 $0
Q1 2022 Aug 23, 2022	BUY	$0.51 - $1.0 $0 - $1	1 New	1 $0
Q2 2019 Aug 08, 2019	SELL	$1.29 - $1.83 $1,677 - $2,379	-1,300 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$1.67 - $3.12 $2,171 - $4,056	1,300 New	1,300 $2,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.